Eyenovia prices public offering of 12.85M shares at $0.40 for ~$5.14M gross proceeds

HYPERION DEFI, INC.

Priced 12,850,000 common shares at $0.40 per share; expected to close August 22, 2024.
Gross proceeds of approximately $5.14 million before fees and expenses.
Proceeds to fund Mydcombi and clobetasol propionate commercialization, CHAPERONE pediatric myopia study, and general corporate purposes.
May also repay portion of existing indebtedness under Loan and Security Agreement with Avenue Capital Management.
Dawson James Securities acting as sole placement agent; offering made under existing S-3 shelf registration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.